Pricing Log in Create free account
Friday 6 November 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue
−0.24%
EPS
+2.48%
Free cash flow
+17.4%
Total debt
+37.5%

Quarter to June 2026, against a year earlier

81.72 7.48 −8.39%
Market cap
$33.9B
P/E
13.4×
Fwd P/E
14.2×
Dividend yield
2.59%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Zoetis Inc. (ZTS) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Zoetis Inc. (ZTS) trades at a P/B ratio of 10.8×. Over the past ten years it has ranged from 9.2× (October 2026) to 26.3× (September 2020); the current reading is higher than 5% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 16.3× 5.31%
FY2024 15.5× (14.58%)
FY2023 18.2× 16.14%
FY2022 15.6× (38.61%)
FY2021 25.5× 22.13%
FY2020 20.9× (10.74%)
FY2019 23.4× 23.57%
FY2018 18.9× (3.94%)
FY2017 19.7× 11.09%
FY2016 17.7× (19.26%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 9.5× (38.23%)
Mar 2026 15.4× (5.54%)
Dec 2025 16.3× 36.09%
Sep 2025 12.0× (13.92%)
42 more quarters

Against its own ten years

Low 9.2× High 26.3×
Ten-year median 18.2×
Current reading's percentile 6

P/B ratio against peers

Company P/B ratio
TAK Takeda Pharmaceutical Co. compare 1.4×
VTRS Viatris Inc. compare 1.6×
ELAN Elanco Animal Health Incorporated compare 1.8×
HLN Haleon PLC Sponsored ADR compare 1.9×
RDY Dr. Reddy's Laboratories Ltd compare 3.0×
UTHR United Therapeutics Corporation compare 3.8×
NBIX Neurocrine Biosciences, Inc. compare 4.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 6.1×
ZTS Zoetis Inc. 10.8×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ZTS